Dengue virus (DENV) is an important human pathogen whose byzantine relationship with the immune response is poorly understood. DENV causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome, diseases for which palliative care is the only treatment. DENV immunopathogenesis studies are complicated by the lack of an immunocompetent small-animal model, and this has hindered anti-DENV drug and vaccine development. This review describes strategies that DENV uses to evade the type I interferon response and focuses on how data gained from the study of DENV NS5-mediated STAT2 degradation may be used to create immunocompetent DENV mouse models and design anti-DENV therapeutics.
STAT2 signaling and dengue virus infection
Juliet Morrison,A. García-Sastre
Published 2014 in JAK-STAT
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
JAK-STAT
- Publication date
2014-01-21
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-63 of 63 references · Page 1 of 1
CITED BY
Showing 1-26 of 26 citing papers · Page 1 of 1